Neupron Pharmaceuticals Private Limited

Neupron Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24299GJ2020PTC114153 Incorporated 26 June 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2024
₹3.51 Cr
▲ 17% YoY
Net profit · FY 2024
₹6.72 Lakh
Net margin 1.9%
EBITDA · FY 2024
₹10.19 Lakh
EBITDA margin 2.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered

About Neupron Pharmaceuticals Private Limited

Data last updated:

Neupron Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 June 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2020PTC114153. Its GSTIN is 24AAGCN9924M1ZX (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rekha Sharma and Ravikumar Ghanshyam Swami.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I – 10 Ratnam Flats B/H – Kundan Tenament Part – 2 Vasna, Ahmedabad, Gujarat, India – 380007.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.51 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹6.72 Lakh (net margin 1.9%) and EBITDA of ₹10.19 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 147% over three years.

Neupron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0010328).

Company details

CIN U24299GJ2020PTC114153
Registration Number 114153
Incorporation Date 26 June 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0010328

Recognitions & Rankings of Neupron Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-GJ-01-0010328

Contact details

Neupron Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    I – 10 Ratnam Flats B/H – Kundan Tenament Part – 2 Vasna, Ahmedabad, Gujarat, India – 380007
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Neupron Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Neupron Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Neupron Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Neupron Pharmaceuticals Private Limited, buy the company report.

Financials of Neupron Pharmaceuticals Private Limited

FY 2025 filings available

Neupron Pharmaceuticals Private Limited reported revenue of ₹3.51 Cr (up 17% YoY) for FY 2024.

Revenue · FY 2024
₹3.51 Cr ▲ 17%
Net profit · FY 2024
₹6.72 Lakh margin 1.9%
EBITDA · FY 2024
₹10.19 Lakh margin 2.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 147%
EBITDA CAGR growth
1 year
▲ 310%
3 years · compounded
▲ 106%

Revenue has grown at a compounded annual rate (CAGR) of 147% over three years, including 17% growth in the latest year. EBITDA rose 310% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.19 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.72 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.9%
Net Profit Margin1.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neupron Pharmaceuticals Private Limited, buy the company report.

Board of directors of Neupron Pharmaceuticals Private Limited

Neupron Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rekha SharmaDirector26 Jun 20206 Years 4 MonthsCurrent
Ravikumar Ghanshyam SwamiDirector26 Jun 20206 Years 4 MonthsCurrent
Ridhima SharmaDirector17 Jun 20251 Years 5 MonthsCurrent

Peer comparison

Neupron Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pritus Healthcare Private Limited₹3.52 Cr (FY 2025)69.0%Ambala City Ho, Haryana, India
Neupron Pharmaceuticals Private Limitedthis company₹3.51 Cr (FY 2024)₹6.72 Lakh1.9%17.0%Ahmedabad, Gujarat, India
Quimico Pharmaceuticals Private Limited₹3.5 Cr (FY 2024)50.0%Jodhpur, Rajasthan, India
City Cat International Limited₹3.5 Cr (FY 2025)-73.0%Mumbai, Maharashtra, India
Genip Pharmaceuticals Private Limited₹3.5 Cr (FY 2025)12.0%Hyderabad, Telangana, India

To see the full peer comparison of Neupron Pharmaceuticals Private Limited, buy the company report.

Auditor

Neupron Pharmaceuticals Private Limited is audited by J S Sisodiya & Company for the financial year 2023.

Auditor firmFinancial yearFirm registration number
J S Sisodiya & CompanyFY 2023159127W

Shareholding

The shareholding of Neupron Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Neupron Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Neupron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Neupron Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 15, 2026.

Active EPFO establishments
1

GST

Neupron Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAGCN9924M1ZXGujaratActive20 Jul 2020
08AAGCN9924M1ZRRajasthanActive10 Oct 2020

To see the full GST registrations and return filing status of Neupron Pharmaceuticals Private Limited, buy the company report.

Recent activity

Neupron Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Ridhima Sharma ceased to be Additional Director on 29 Sep 2025.

AGM
Neupron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Ridhima Sharma ceased to be Additional Director.
Appointed
Ridhima Sharma was appointed as Director.
Filing
Neupron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Ravikumar Ghanshyam Swami was appointed as Director.
Appointed
Rekha Sharma was appointed as Director.
Incorporation
26 Jun 2020
Neupron Pharmaceuticals Private Limited was registered on 26 Jun 2020 with Roc Ahmedabad & aged 6 years 4 months as per MCA records.

Frequently asked questions

Neupron Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 June 2020 (6+ years old) and is registered under CIN U24299GJ2020PTC114153.

Neupron Pharmaceuticals has 3 current directors:

The latest financial statements of Neupron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Neupron Pharmaceuticals is 24AAGCN9924M1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAGCN9924M1ZR (Rajasthan).

The CIN (Corporate Identification Number) of Neupron Pharmaceuticals is U24299GJ2020PTC114153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neupron Pharmaceuticals was incorporated on 26 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Neupron Pharmaceuticals by revenue are Pritus Healthcare Private Limited, Quimico Pharmaceuticals Private Limited, City Cat International Limited, Genip Pharmaceuticals Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (wholesale trading).

Ridhima Sharma ceased to be Additional Director on 29 Sep 2025. Ridhima Sharma was appointed as Director on 17 Jun 2025. Ravikumar Ghanshyam Swami was appointed as Director on 26 Jun 2020. Neupron Pharmaceuticals has 4 board changes on record in total.

Yes, Neupron Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Neupron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0010328).

The registered office of Neupron Pharmaceuticals is at I – 10 Ratnam Flats BH – Kundan Tenament Part – 2 Vasna, Ahmedabad, Gujarat, India – 380007.